BrYet gets AIFA approval for cGMP line for ML-016
BrYet announced AIFA approval of a first-in-kind cGMP manufacturing line for ML-016, supporting imminent clinical supply to Australia.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BrYet announced AIFA approval of a first-in-kind cGMP manufacturing line for ML-016, supporting imminent clinical supply to Australia.